Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arch Venture Fund Vi Lp


  • Large Shareholder at Quanterix Corp (QTRX), 2017-12-13
  • Large Shareholder at Xtera Communications Inc. (XCOM), 2016-10-13
  • Large Shareholder at Adesto Technologies Corp (IOTS), 2015-11-04
  • Large Shareholder at Vbi Vaccines Inc. (VBIV), 2015-08-17
  • Large Shareholder at Bellerophon Therapeutics Inc. (BLPH), 2015-02-24
  • Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
  • Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
  • Large Shareholder at Fate Therapeutics Inc (FATE), 2013-10-07
  • Large Shareholder at Kythera Biopharmaceuticals Inc (KYTH), 2012-10-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
QTRX $15.00 266,000 Large Shareholder 1,537,684 2017-12-11 Filing
XCOM $5.00 300,000 Large Shareholder 1,885,090 2015-11-17 Filing
XCOM $5.00 300,000 Large Shareholder 1,885,090 2015-11-17 Filing
IOTS $5.00 400,000 Large Shareholder 400,000 2015-10-26 Filing
BLPH $12.00 212,666 Large Shareholder 965,660 2015-02-19 Filing